We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

5 hedge funds and large institutions have $142K invested in InspireMD, Inc. Series B Warrants in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 3 → 5 (+2)

12% less capital invested

Capital invested by funds: $162K → $142K (-$20K)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$21.3K
2
VF
Virtu Financial
New York
+$5.91K
3
UBS Group
UBS Group
Switzerland
+$524
4
SM
Sabby Management
Florida
+$26

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$100K +$21.3K +250,000 New
SM
2
Sabby Management
Florida
$40K +$26 +300 +0%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$2K – – –
UBS Group
4
UBS Group
Switzerland
– +$524 +6,148 New
VF
5
Virtu Financial
New York
– +$5.91K +69,272 New

NSPRZ Hedge Fund Activity: Q3 2017 in Review

5 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q3 2017, worth a combined $142K — down 12% from $162K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NSPRZ positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $21.3K.

  • 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q3 2017, up from 3 in Q2 2017.
  • Funds reported $142K of InspireMD, Inc. Series B Warrants stock for Q3 2017, down 12% quarter-over-quarter.
  • 3 funds opened new InspireMD, Inc. Series B Warrants positions in Q3 2017 and 0 closed out, a net change of +3 holders.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q3 2017 was Anson Funds Management, an estimated $21.3K added.

Based on aggregated 13F filings for Q3 2017.